NBT Analytics Competitors and Similar CompaniesClear all

Opko Health's competitors and similar companies include IntegraGen.
Opko Health
Opko Health
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
IntegraGen
IntegraGen
IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.
Founding Date
Founding Date
2007
Founding Date
2000
Type
Type
Public
Type
Public
Tags
Locations
Locations
Miami, US HQ
Woburn, US
Locations
Évry, FR HQ
Cambridge, US
Employees
Employees
6,0967% increase
Employees
4420% decrease
Valuation ($)
Valuation ($)
1.1 b
Valuation ($)
3.8 m

Financial

Revenue (est.)
Revenue (est.)
$606.9m (FY, 2025)
Revenue (est.)
€5m (FY, 2025)
Cost of goods
Cost of goods
$400.9m (FY, 2025)
Cost of goods
€1.8m (FY, 2025)
Gross profit
Gross profit
$205.9m (FY, 2025)
Gross profit
€3.5m (FY, 2025)
Net income
Net income
($225.7m) (FY, 2025)
Net income
(€2.7m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 31m
Total funding raised
$ 14.3m
For sources of this data, please see the company profile

View Company Profiles

IntegraGen
HQ
Évry, FR
Employees
44↓ 20% decrease

IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.

View company